Literature DB >> 11123872

Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.

C Y Fan1.   

Abstract

Head and neck squamous cell carcinomas (HNSCC) arise as a consequence of cumulative genetic changes brought about by continued exposure to carcinogens associated with tobacco and alcohol use, influenced by viral agents such as human papillomaviruses, in a background of acquired or heritable genetic susceptibility. The presence of widespread genomic instability in HNSCC, such as cytogenetic aberrations, allelic imbalance/loss of heterozygosity, and microsatellite instability, suggests that there is an imperfection in the host DNA repair machinery. Genomic instability with progressive accumulation of detrimental genetic alterations appears to be dependent upon a circuitous interaction between the environmental genotoxic insults and the host DNA repair machinery, the functional integrity of which is governed by the proper cell cycle control and host DNA repair capacity. Thus, it can be hypothesized that continued exposure to environmental carcinogens (ie, longstanding history of smoking and drinking), loss of proper cell cycle control (eg, inactivation of p53 or p16 tumor suppressor genes or amplification of the proto-oncongene cyclin D1), and impaired DNA repair capacity (both inherited and acquired) are prerequisites in head and neck carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123872     DOI: 10.1007/s11912-001-0045-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  48 in total

1.  Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.

Authors:  H Shiga; E I Heath; A A Rasmussen; B Trock; P G Johnston; A A Forastiere; M Langmacher; A Baylor; M Lee; K J Cullen
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

2.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

Authors:  M Sanchez-Cespedes; M Esteller; L Wu; H Nawroz-Danish; G H Yoo; W M Koch; J Jen; J G Herman; D Sidransky
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

3.  Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer.

Authors:  Q Wei; S A Eicher; Y Guan; L Cheng; J Xu; L N Young; K C Saunders; H Jiang; W K Hong; M R Spitz; S S Strom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-04       Impact factor: 4.254

4.  Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck.

Authors:  E M Sturgis; E J Castillo; L Li; R Zheng; S A Eicher; G L Clayman; S S Strom; M R Spitz; Q Wei
Journal:  Carcinogenesis       Date:  1999-11       Impact factor: 4.944

Review 5.  Clinical implications of the p53 gene.

Authors:  D Sidransky; M Hollstein
Journal:  Annu Rev Med       Date:  1996       Impact factor: 13.739

6.  Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.

Authors:  O Gallo; I Chiarelli; V Boddi; C Bocciolini; L Bruschini; B Porfirio
Journal:  Int J Cancer       Date:  1999-12-22       Impact factor: 7.396

7.  Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer.

Authors:  P U Hegde; A C Brenski; D D Caldarelli; J Hutchinson; W R Panje; N B Wood; S Leurgans; H D Preisler; S G Taylor; L Caldarelli; J S Coon
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-01

8.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

9.  A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer.

Authors:  G Strathdee; M J MacKean; M Illand; R Brown
Journal:  Oncogene       Date:  1999-04-08       Impact factor: 9.867

10.  Reduced DNA repair capacity in head and neck cancer patients.

Authors:  L Cheng; S A Eicher; Z Guo; W K Hong; M R Spitz; Q Wei
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-06       Impact factor: 4.254

View more
  8 in total

1.  Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma.

Authors:  Tasmin Reuter; Rolf Warta; Dirk Theile; Andreas D Meid; Juan Pablo Rigalli; Carolin Mogler; Esther Herpel; Niels Grabe; Bernd Lahrmann; Peter K Plinkert; Christel Herold-Mende; Gerhard Dyckhoff; Walter Emil Haefeli; Johanna Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-07-04       Impact factor: 3.000

2.  Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma.

Authors:  Mirko Kontić; Jovica Milovanović; Zaviša Čolović; Nikola Kolja Poljak; Željko Šundov; Ante Sučić; Valdi Pešutić-Pisac
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-08       Impact factor: 2.503

Review 3.  Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications.

Authors:  Chun-Yang Fan
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

Review 4.  ErbB receptors in the biology and pathology of the aerodigestive tract.

Authors:  Sarah Morgan; Jennifer R Grandis
Journal:  Exp Cell Res       Date:  2008-08-23       Impact factor: 3.905

5.  Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.

Authors:  Bhuvanesh Singh; Volkert B Wreesmann; David Pfister; Ashok Poluri; Ashok R Shaha; Dennis Kraus; Jatin P Shah; Pulivarthi H Rao
Journal:  BMC Genet       Date:  2002-11-14       Impact factor: 2.797

6.  Integrated analysis revealing genome-wide chromosomal copy number variation in supraglottic laryngeal squamous cell carcinoma.

Authors:  Dongjie Li; Xianfu Wang; Shunfei Lu; Ping Wang; Xin Wang; Wanzhong Yin; Wei Zhu; Shibo Li
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

7.  Impact of polymorphisms in DNA repair genes XPD, hOGG1 and XRCC4 on colorectal cancer risk in a Chinese Han Population.

Authors:  Dexi Jin; Min Zhang; Hongjun Hua
Journal:  Biosci Rep       Date:  2019-01-15       Impact factor: 3.840

8.  Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer.

Authors:  M M Sasiadek; A Stembalska-Kozlowska; R Smigiel; D Ramsey; T Kayademir; N Blin
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.